Medical Equipment

Structural Heart Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Structural Heart Market Expected to Grow Between 2025 And 2029?

The growth of the structural heart market size has been remarkable in the past few years. There is a predicted increase from $14.9 billion in 2024 to $15.89 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.6%. The expansion in the historic period is due to heightened awareness and screening, robustness in the supply chain, increased spending on healthcare, market consolidation, and growing consciousness about cardiovascular diseases.

In the upcoming years, the structural heart market is predicted to witness a robust expansion. By 2029, it is anticipated to swell to a substantial $22.48 billion, with a compound annual growth rate (CAGR) of 9.1%. The surge in this projected period is due to factors such as need for heart valve devices, an older population, escalating cardiovascular diseases, market division, and regional market expansion. Noteworthy trends during this forecast span comprise of new product introductions, advancements in technology, an economic resurgence, implementation of regulations, increasing occurrences of cardiovascular ailments, and groundbreaking medical apparatuses.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12029&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theStructural Heart Market?

Heightening occurrences of cardiovascular disorders are foreseen to fuel the expansion of the structural heart industry. Such afflictions impact the heart and blood vessels, encompassing conditions like coronary artery disease, heart failure, and stroke. The escalation in these disorders is predominantly attributable to the aging populace, lifestyle and dietary modifications, and an upward trend in obesity and diabetes. Devices and treatments for structural heart conditions provide diagnosis and remediation of such irregularities or illnesses that impact the valves, chambers, and surrounding tissues employing less invasive methods as an alternative to open-heart surgeries, rendering more efficient care with reduced risk of complications. For instance, an August 2022 report by the American College of Cardiology, a US-based non-profit medical group, projected increases in each of the four cardiovascular risk factors in the United States between 2025 and 2060. The most significant rise is foreseen in diabetes, with an upsurge of 39.3% to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). The study also found the greatest projected increments in cardiovascular disease rates to be in stroke (33.8% to 15 million) and heart failure (33.4% to 13 million), followed by ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million). Hence, the escalation in cardiovascular disorders is bolstering the expansion of the structural heart market.

Which Segments in the Structural Heart Offer the Most Growth?

The structural heartmarket covered in this report is segmented –

1) By Product: Occluders, Annuloplasty Rings, Heart Valve Balloons, Other Products

2) By Procedure: Heart Valve Stenosis, Heart Valve Regurgitation, Left Atrial Appendage Closure

3) By End Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers

Subsegments:

1) By Occluders: Atrial Septal Defect (ASD) Occluders, Patent Foramen Ovale (PFO) Occluders, Ventricular Septal Defect (VSD) Occluders

2) By Annuloplasty Rings: Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Adjustable Annuloplasty Rings

3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems, Valvuloplasty Balloons

4) By Other Products: Transcatheter Heart Valves, Structural Heart Imaging Devices, Delivery Systems For Structural Heart Procedures

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12029&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theStructural Heart Market?# Market?

North America was the largest region in the structural heart market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Structural Heart Industry?

The progression of technology has emerged as a vital trend, gaining traction in the structural heart market. Major players in the structural heart market are focusing their resources on the development of novel products to consolidate their market position. For example, Eko Health, a digital health company based in the US, introduced the SENSORA cardiac disease detection platform in February 2023. This platform, targeted towards primary care, allows for non-invasive detection of heart diseases. SENSORA utilizes artificial intelligence to accurately detect structural murmurs, indicative of valvular heart disease, and features a care pathway analytics software that offers insight into the patient’s journey through the healthcare system. This is achieved by capturing and analyzing heart sounds and electrical signals using digital stethoscopes. It is designed to assist in crucial decision-making processes by identifying gaps in care that can be converted into improved operational efficiency, including reducing delays in care provision, minimizing length of stay and readmission rates, while simultaneously improving patient and doctor satisfaction.

View the full report here:

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

What Are the Key Elements That Define the Structural Heart Market?

Structural heart refers to a subspecialty within cardiology that focuses on the diagnosis and treatment of structural abnormalities or diseases of the heart, particularly those affecting the valves, chambers, and surrounding structures. It typically involves minimally invasive procedures performed in a catheterization laboratory rather than open-heart surgery.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12029

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model